Study for the Recording of Adherence to Treatment With Perindopril/Indapamide/Amlodipine Fixed Dose Combination (CONTROL-3)

Servier

Status: Completed

Conditions: Adherence to Medication Regime; Hypertensive Disease

Treatments: Drug: Perindopril/Indapamide/Amlodipine fixed dose combination

Study type: Observational

Funder types: Industry

Identifiers

NCT02655029

IC4-06593-021-GRC

Details and patient eligibility

About

The main objective of this study is to record, in routine clinical practice, patients' adherence to treatment with Perindopril/Indapamide/Amlodipine fixed dose combination, during 4 months treatment.

Full description

This is a non-interventional study aiming to record adherence to treatment with Perindopril/Indapamide/Amlodipine fixed dose combination. In parallel blood pressure levels will be recorded, as well as safety and tolerability of this fixed dose combination.

Enrollment: 2,285 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Male or female, ambulatory patients >18 years old.
• Clinically diagnosed essential arterial hypertension.
• Under treatment with Perindoril/Indapamide/Amlodipine fixed dose combination.
• The patient has given his/her written consent after being informed, before his inclusion in the study.

Exclusion criteria

• Secondary arterial hypertension.
• Serious end stage diseases, severe neuropsychiatric diseases, cerebrovascular event with serious residual lesions, scheduled procedure or surgical operation or hospital admission.
• Pregnancy, lactation or intention to become pregnant.